Calyxt
NASDAQ: CBUSNew Brighton, US · Delaware corporation
Find your way into Calyxt
Sign up to see every warm intro you have to Calyxt
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Calyxt team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Cibus develops gene-edited plant traits for major agricultural crops using its proprietary Rapid Trait Development System, which it licenses to seed companies for royalties. The company focuses primarily on productivity traits such as herbicide tolerance and disease resistance for rice, canola, and soybean, targeting markets in the Americas, Asia, and other regions where regulatory environments permit gene-edited crop commercialization.
Founders & leadership

Reported raises · per SEC filings
Form D private placements$47.5M disclosed across 1 round · 2017
▶$47.5MraisedJun 2017 · 48 investors · AgricultureRule 506(b)
- Feng ZhangExecutive Officer
- Glenn M. BowersExecutive Officer
- Daniel VoytasExecutive Officer
- Manoj SahooExecutive Officer
- Federico A. TripodiExecutive Officer
- Michel ArbadjiExecutive Officer
- Andre ChoulikaDirector
- Joseph B. SaluriExecutive Officer
- Bryan W.J. CorkalExecutive Officer
- Amount sold
- $47.5M
- First sale
- Jun 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Valuation · disclosed
Disclosed eventsSource: SEC prospectus filings, and round valuations the company or its investors disclosed — follow each entry's link for the claim.
Frequently asked questions
- What does Calyxt do?
- Cibus develops gene-edited plant traits for major agricultural crops using its proprietary Rapid Trait Development System, which it licenses to seed companies for royalties. The company focuses primarily on productivity traits such as herbicide tolerance and disease resistance for rice, canola, and soybean, targeting markets in the Americas, Asia, and other regions where regulatory environments permit gene-edited crop commercialization.
- Who founded Calyxt?
- Calyxt was founded by Daniel Voytas.
- How much funding has Calyxt raised?
- Calyxt has disclosed $47.5M raised across 1 round.
- Where is Calyxt headquartered?
- Calyxt is headquartered in New Brighton, US.